The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection. uri icon

authors

  • Snee, M P
  • Bestall, J
  • Hewison, J
  • Hinsley, S
  • Franks, K
  • McParland, L
  • Collinson, F
  • Lowe, C M
  • Striha, A
  • Baldwin, D R
  • Naidu, B
  • Sebag-Montefiore, D
  • Gregory, W M

publication date

  • January 1, 2016